Suppr超能文献

相似文献

1
A Dual-Functioning 5'-PPP-NS1shRNA that Activates a RIG-I Antiviral Pathway and Suppresses Influenza NS1.
Mol Ther Nucleic Acids. 2020 Mar 6;19:1413-1422. doi: 10.1016/j.omtn.2020.01.025. Epub 2020 Jan 31.
3
Role of the Chaperone Protein 14-3-3ε in the Regulation of Influenza A Virus-Activated Beta Interferon.
J Virol. 2021 Sep 27;95(20):e0023121. doi: 10.1128/JVI.00231-21. Epub 2021 Aug 11.
4
West Nile Virus NS1 Antagonizes Interferon Beta Production by Targeting RIG-I and MDA5.
J Virol. 2017 Aug 24;91(18). doi: 10.1128/JVI.02396-16. Print 2017 Sep 15.
5
Avian Influenza NS1 Proteins Inhibit Human, but Not Duck, RIG-I Ubiquitination and Interferon Signaling.
J Virol. 2022 Sep 28;96(18):e0077622. doi: 10.1128/jvi.00776-22. Epub 2022 Sep 7.
8
The 3' untranslated regions of influenza genomic sequences are 5'PPP-independent ligands for RIG-I.
PLoS One. 2012;7(3):e32661. doi: 10.1371/journal.pone.0032661. Epub 2012 Mar 15.
9
Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists.
J Virol. 2015 Aug;89(15):8011-25. doi: 10.1128/JVI.00845-15. Epub 2015 May 27.

引用本文的文献

1
Femtosecond laser-ablative aqueous synthesis of multi-drug antiviral nanoparticles.
Nanomedicine (Lond). 2025 Apr;20(7):691-699. doi: 10.1080/17435889.2025.2473307. Epub 2025 Mar 13.
2
Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches.
Cell Mol Life Sci. 2025 Feb 13;82(1):75. doi: 10.1007/s00018-025-05611-1.
3
Antiviral Approaches against Influenza Virus.
Clin Microbiol Rev. 2023 Mar 23;36(1):e0004022. doi: 10.1128/cmr.00040-22. Epub 2023 Jan 16.
4
Enhancing anti-tumor efficacy and immune memory by combining 3p-GPC-3 siRNA treatment with PD-1 blockade in hepatocellular carcinoma.
Oncoimmunology. 2022 Jan 2;11(1):2010894. doi: 10.1080/2162402X.2021.2010894. eCollection 2022.

本文引用的文献

1
Systematic Screening, Rational Development, and Initial Optimization of Efficacious RNA Silencing Agents for Human Rod Opsin Therapeutics.
Transl Vis Sci Technol. 2019 Dec 12;8(6):28. doi: 10.1167/tvst.8.6.28. eCollection 2019 Nov.
2
New immunodeficiency syndromes that help us understand the IFN-mediated antiviral immune response.
Curr Opin Pediatr. 2019 Dec;31(6):815-820. doi: 10.1097/MOP.0000000000000827.
3
Baloxavir and Treatment-Emergent Resistance: Public Health Insights and Next Steps.
J Infect Dis. 2020 Jan 14;221(3):337-339. doi: 10.1093/infdis/jiz245.
7
The highly efficient T7 RNA polymerase: A wonder macromolecule in biological realm.
Int J Biol Macromol. 2018 Oct 15;118(Pt A):49-56. doi: 10.1016/j.ijbiomac.2018.05.198. Epub 2018 May 27.
8
Baloxavir: First Global Approval.
Drugs. 2018 Apr;78(6):693-697. doi: 10.1007/s40265-018-0899-1.
9
Oseltamivir-resistant influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015.
J Med Virol. 2018 May;90(5):836-843. doi: 10.1002/jmv.25013. Epub 2018 Feb 9.
10
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.
Lancet. 2018 Mar 31;391(10127):1285-1300. doi: 10.1016/S0140-6736(17)33293-2. Epub 2017 Dec 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验